415 related articles for article (PubMed ID: 26538238)
1. Reactive oxygen species: players in the cardiovascular effects of testosterone.
Tostes RC; Carneiro FS; Carvalho MH; Reckelhoff JF
Am J Physiol Regul Integr Comp Physiol; 2016 Jan; 310(1):R1-14. PubMed ID: 26538238
[TBL] [Abstract][Full Text] [Related]
2. Vascular Pathways of Testosterone: Clinical Implications.
Lorigo M; Mariana M; Oliveira N; Lemos MC; Cairrao E
J Cardiovasc Transl Res; 2020 Feb; 13(1):55-72. PubMed ID: 31820333
[TBL] [Abstract][Full Text] [Related]
3. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
[TBL] [Abstract][Full Text] [Related]
4. Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications.
Lucas-Herald AK; Alves-Lopes R; Montezano AC; Ahmed SF; Touyz RM
Clin Sci (Lond); 2017 Jul; 131(13):1405-1418. PubMed ID: 28645930
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cardiovascular cellular processes by S-nitrosylation.
Schulman IH; Hare JM
Biochim Biophys Acta; 2012 Jun; 1820(6):752-62. PubMed ID: 21536106
[TBL] [Abstract][Full Text] [Related]
6. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
Traish AM
Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
[TBL] [Abstract][Full Text] [Related]
7. Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation.
Tejero J; Shiva S; Gladwin MT
Physiol Rev; 2019 Jan; 99(1):311-379. PubMed ID: 30379623
[TBL] [Abstract][Full Text] [Related]
8. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature.
Herring MJ; Oskui PM; Hale SL; Kloner RA
J Am Heart Assoc; 2013 Jul; 2(4):e000271. PubMed ID: 23842280
[No Abstract] [Full Text] [Related]
9. Nitric oxide signalling in cardiovascular health and disease.
Farah C; Michel LYM; Balligand JL
Nat Rev Cardiol; 2018 May; 15(5):292-316. PubMed ID: 29388567
[TBL] [Abstract][Full Text] [Related]
10. Sex hormones in the cardiovascular system.
dos Santos RL; da Silva FB; Ribeiro RF; Stefanon I
Horm Mol Biol Clin Investig; 2014 May; 18(2):89-103. PubMed ID: 25390005
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
Jones TH; Kelly DM
Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
[TBL] [Abstract][Full Text] [Related]
12. Testosterone therapy and prostate cancer--safety concerns are well founded.
Klotz L
Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
Montezano AC; Touyz RM
Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
[TBL] [Abstract][Full Text] [Related]
14. Testosterone and the Heart.
Goodale T; Sadhu A; Petak S; Robbins R
Methodist Debakey Cardiovasc J; 2017; 13(2):68-72. PubMed ID: 28740585
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-generated reactive oxygen species in brain and pathogenesis of cardiovascular diseases.
Chan SH; Chan JY
Antioxid Redox Signal; 2013 Oct; 19(10):1074-84. PubMed ID: 22429119
[TBL] [Abstract][Full Text] [Related]
17. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
[TBL] [Abstract][Full Text] [Related]
18. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.
Oskui PM; French WJ; Herring MJ; Mayeda GS; Burstein S; Kloner RA
J Am Heart Assoc; 2013 Nov; 2(6):e000272. PubMed ID: 24242682
[No Abstract] [Full Text] [Related]
19. Role of androgens in cardiovascular pathology.
Chistiakov DA; Myasoedova VA; Melnichenko AA; Grechko AV; Orekhov AN
Vasc Health Risk Manag; 2018; 14():283-290. PubMed ID: 30410343
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II and oxidative stress.
Hitomi H; Kiyomoto H; Nishiyama A
Curr Opin Cardiol; 2007 Jul; 22(4):311-5. PubMed ID: 17556883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
